A detailed history of Rollins Financial Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Rollins Financial Advisors, LLC holds 2,432 shares of NVO stock, worth $267,836. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,432
Previous 3,072 20.83%
Holding current value
$267,836
Previous $394 Million 11.99%
% of portfolio
0.06%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $78,534 - $94,022
-640 Reduced 20.83%
2,432 $347 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $83,934 - $111,726
-822 Reduced 21.11%
3,072 $394 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $341,815 - $410,622
3,894 New
3,894 $403 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Rollins Financial Advisors, LLC Portfolio

Follow Rollins Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rollins Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rollins Financial Advisors, LLC with notifications on news.